AlphaNavi Pharma
Latest round
- Series B
Last raised
- Mar 2023
Total raised
- $13M
Investors
- 6
About AlphaNavi Pharma
AlphaNavi Pharma was founded in 2019 and is headquartered in Suita-shi, Japan. The company specializes in developing pharmaceutical products, particularly targeting chronic pain and specific conditions such as Familial Infantile Episodic Limb Pain.AlphaNavi Pharma Inc. specializes in the research and development of innovative pharmaceutical products aimed at alleviating chronic and discomforting pain, as well as addressing specific medical conditions such as Familial Infantile Episodic Limb Pain. Their core product offerings include novel drugs in various stages of clinical development, prominently featuring DSP-3905, which targets neuropathic pain.AlphaNavi Pharma's revenue is primarily generated through partnerships and collaborations within the pharmaceutical sector, particularly focused on the development and commercialization of their drug candidates. The company collaborates with healthcare institutions and pharmaceutical partners to establish agreements that facilitate the distribution of their innovative treatments. The company plans to leverage these funds to enhance the development of DSP-3905 and potentially introduce new products targeting additional medical conditions. Furthermore, AlphaNavi Pharma is exploring opportunities to expand into new geographical markets, with specific strategies targeting regions beyond Japan, aiming for broader distribution of their medical solutions.
Who invested in AlphaNavi Pharma
6 investors across 2 rounds
See all investors in AlphaNavi Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AlphaNavi Pharma
Who invested in AlphaNavi Pharma?
AlphaNavi Pharma has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AlphaNavi Pharma raised?
AlphaNavi Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AlphaNavi Pharma last raise money?
AlphaNavi Pharma's most recent round on record is a Series B, in Mar 2023.
What does AlphaNavi Pharma do?
AlphaNavi Pharma was founded in 2019 and is headquartered in Suita-shi, Japan.
Where is AlphaNavi Pharma headquartered?
AlphaNavi Pharma is headquartered in Suita-shi, Japan.
Which VCs invest in companies like AlphaNavi Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at AlphaNavi Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like AlphaNavi Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.